SBLENDORIO GLENN 4
4 · AMICUS THERAPEUTICS, INC. · Filed Mar 11, 2024
Insider Transaction Report
Form 4
SBLENDORIO GLENN
Director
Transactions
- Exercise/Conversion
Common Stock
2024-03-07$2.80/sh+15,000$42,000→ 83,596 total - Exercise/Conversion
Stock Options (right to buy)
2024-03-07−15,000→ 0 totalExercise: $2.80Exp: 2024-06-12→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]All of the options were fully vested and exercisable as of the transaction date.